Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
News|Webcasts|August 24, 2023
Optimizing evidence and design using the patient’s lens
Author(s)Medable
In this webinar, experts will showcase why patient preferences, site preferences, and digital endpoints must be considered early in the protocol design discussion.
Register Free:
Event Overview:
With ACRP stating that “clinical trial complexity levels show an unrelenting increase,” it’s increasingly important to use past experiences and quality by design to help prevent study issues before they begin. Far too often, sponsors and CROs experience difficulties in trial conduct because its challenging to realize the impact of their clinical trial processes on human lives.
Learn why a perspective that combines the lens of lived patient and caregiver experiences is so important and effective to incorporate upfront in today’s trial design. Uncover how Medable has worked with customers to drive success, by empowering patient-centric insights that have shaped everything from protocols to data collection.
Webinar Highlights:
- Patient-Centric Insights: Discover how real-life experiences enrich protocol narratives, fostering patient loyalty and commitment.
- Fine-Tuning for Success: Learn how our collaboration enhances your protocols for optimal retention and compliance.
- Early Engagement Magic: Uncover the power of early partnership with use cases that highlight our success with customers.
- Live Q&A Session: Have burning questions? Ask the experts and patients who are here to provide insightful answers and guidance.
Featured Speakers:
Dr. Pamela Tenaerts
Chief Scientific Officer
Medable
As Chief Scientific Officer, Dr. Pamela Tenaerts oversees Medable’s clinical research department to help identify, develop, and implement responsible decentralized trial strategies for sponsors, sites, and patients. Dr Tenaerts brings more than 30 years of experience in clinical trials as a researcher, academic, and physician, most recently serving as Executive Director of the Clinical Trials Transformation Initiative (CTTI) at Duke University. She is a board member of the Society of Clinical Trials and the Scientific Leadership Council of the Digital Medicine Society and participates in the Good Clinical Trial Collaborative and the National Academies of Science and Medicine: Forum on Drug Discovery, Development, and Translation. She received her MD from KU Leuven and her MBA from the University of South Florida.
Jena Daniels
VP Patient Success
Medable
Jena Daniels is an experienced research manager with 10 years of experience in enabling digital solutions within academic and industry sponsored clinical trials. As a 2021 PharmaVoice100 recipient and Best Decentralized Clinical Trial Businesswoman of 2022, Jena is most known for establishing Medable's Patient Success department and Patient Caregiver Network. These teams engage and empower expert patient and caregiver advocates to assist product development, refine study workflows, and tailor the overall trial experience. This results in meaningful, actionable, and patient-focused solutions. She is incredibly passionate about enabling effective therapies to get to patients faster by disrupting legacy standards with scalable and personalized digital solutions. Prior to Medable, she worked as a Clinical Research Manager at Harvard Medical School and Stanford University School of Medicine. She has co-authored over 30 peer-reviewed publications focusing on how to leverage machine-learning, artificial intelligence, and remote patient monitoring to triage, diagnose, and provide early intervention for children with autism spectrum disorder.
Register Free:
Related to this article
Clinical trial endpoints define what success looks like, but patients and caregivers are rarely the ones setting that definition, and the gap between what trials measure and what patients actually value is showing up in post-approval evidence, regulatory submissions, and the design rooms where protocols are written.
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the real advantage of faster data isn’t speed—it’s shortening the distance between signals, human judgment, and the next best action.
In this Q&A, Saamir Pasha and Carole Berini, PhD, of Ontada discuss what it takes to harmonize fragmented oncology data into reliable real-world evidence, how lab markers can proxy for missing functional status data, and where the biggest remaining barriers to consistent RWE generation lie.
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.
Trending on Applied Clinical Trials Online
1
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
2
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
3
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
4
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
5